Cyclin-dependent kinase inhibitor p21 in endometrial carcinoma

被引：0
|
作者：
Backe, J
Caffier, H
Dietl, J
机构：
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1997年 / 177卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [41] The Cyclin-Dependent Kinase Inhibitor p21 Is a Crucial Target for Histone Deacetylase 1 as a Regulator of Cellular Proliferation
    Zupkovitz, Gordin
    Grausenburger, Reinhard
    Brunmeir, Reinhard
    Senese, Silvia
    Tischler, Julia
    Jurkin, Jennifer
    Rembold, Martina
    Meunier, Dominique
    Egger, Gerda
    Lagger, Sabine
    Chiocca, Susanna
    Propst, Fritz
    Weitzer, Georg
    Seiser, Christian
    MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (05) : 1171 - 1181
  • [42] The role of the cyclin-dependent kinase inhibitor p21(WAF1) in the maintenance of differentiating hepatoma cells
    Ebinuma, H
    Saito, H
    Tada, S
    Kurose, I
    Kaneko, F
    Takahashi, M
    Ohishi, T
    Watanabe, T
    Ishii, H
    GASTROENTEROLOGY, 1997, 112 (04) : A1259 - A1259
  • [43] Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation
    Welling, Theodore H.
    Lu, Guanyi
    Csencsits, Keri
    Wood, Sherri C.
    Jarvinen, Lamis
    Bishop, Keith
    SURGERY, 2008, 143 (03) : 394 - 403
  • [44] The cyclin-dependent kinase inhibitor p21(WAF1) IS required for survival of differentiating neuroblastoma cells
    Poluha, W
    Poluha, DK
    Chang, BC
    Crosbie, NE
    Schonhoff, CM
    Kilpatrick, DL
    Ross, AH
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (04) : 1335 - 1341
  • [45] Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity
    Moussa, Rayan S.
    Park, Kyung Chan
    Kovacevic, Zaklina
    Richardson, Des R.
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 : 276 - 294
  • [46] Role of cyclin-dependent kinase inhibitors p21 and p27 in arterial thrombosis
    Breitenstein, A.
    Akhmedov, A.
    Luescher, T. F.
    Tanner, F. C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 951 - 952
  • [47] MOLECULAR EXPRESSION OF CYCLIN DEPENDENT KINASE INHIBITOR (p21) IN CANINE TUMORS
    Manzoor, S.
    Saif, R.
    Sadia, H.
    Firyal, S.
    Tayyab, M.
    Mansha, M.
    Mahmood, A. K.
    Hashmi, A. S.
    Awan, A. R.
    Wasim, M.
    JOURNAL OF ANIMAL AND PLANT SCIENCES, 2019, 29 (04): : 1127 - 1134
  • [48] Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53
    Tang, H
    Zhao, K
    Pizzolato, JF
    Fonarev, M
    Langer, JC
    Manfredi, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 29156 - 29163
  • [49] Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21(waf-1) in human cutaneous squamous cell carcinoma
    Tron, VA
    Tang, LR
    Yong, WP
    Trotter, MJ
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (04): : 1139 - 1146
  • [50] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
    APRELIKOVA, O
    XIONG, Y
    LIU, ET
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
12345